Literature DB >> 33841626

Paving the way for small-molecule drug discovery.

Yu-Shui Ma1,2,3, Rui Xin3, Xiao-Li Yang3, Yi Shi2, Dan-Dan Zhang3, Hui-Min Wang2, Pei-Yao Wang3, Ji-Bin Liu2, Kai-Jian Chu4, Da Fu3.   

Abstract

Small-molecule drugs are organic compounds affecting molecular pathways by targeting important proteins, which have a low molecular weight, making them penetrate cells easily. Small-molecule drugs can be developed from leads derived from rational drug design or isolated from natural resources. As commonly used medications, small-molecule drugs can be taken orally, which enter cells to act on intracellular targets. These characteristics make small-molecule drugs promising candidates for drug development, and they are increasingly favored in the pharmaceutical market. Despite the advancements in molecular genetics and effective new processes in drug development, the drugs currently used in clinical practice are inadequate due to their poor efficacy or severe side effects. Therefore, developing new safe and efficient drugs is a top priority for disease control and curing. AJTR
Copyright © 2021.

Keywords:  Small-molecule drugs; cancer; compound; molecular genetics; natural resource

Year:  2021        PMID: 33841626      PMCID: PMC8014367     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  175 in total

1.  Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.

Authors:  Mohammed Selman; Christopher Rousso; Anabel Bergeron; Hwan Hee Son; Ramya Krishnan; Nader A El-Sayes; Oliver Varette; Andrew Chen; Fabrice Le Boeuf; Fanny Tzelepis; John C Bell; Debbie C Crans; Jean-Simon Diallo
Journal:  Mol Ther       Date:  2017-10-24       Impact factor: 11.454

Review 2.  Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment.

Authors:  Shu Chun Chang; Jeak Ling Ding
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-08-21       Impact factor: 10.680

3.  Systemically Administered Sindbis Virus in Combination with Immune Checkpoint Blockade Induces Curative Anti-tumor Immunity.

Authors:  Iris Scherwitzl; Alicia Hurtado; Carolyn M Pierce; Sandra Vogt; Christine Pampeno; Daniel Meruelo
Journal:  Mol Ther Oncolytics       Date:  2018-05-03       Impact factor: 7.200

Review 4.  Biological Considerations in Scaling Up Therapeutic Cell Manufacturing.

Authors:  Darshana S Cherian; Tejasvini Bhuvan; Laurence Meagher; Tracy S P Heng
Journal:  Front Pharmacol       Date:  2020-05-13       Impact factor: 5.810

5.  Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer.

Authors:  Dongqiang Zeng; Zilan Ye; Jiani Wu; Rui Zhou; Xinxiang Fan; Gaofeng Wang; Yiqiang Huang; Jianhua Wu; Huiying Sun; Miaohong Wang; Jianping Bin; Yulin Liao; Nailin Li; Min Shi; Wangjun Liao
Journal:  Theranostics       Date:  2020-05-25       Impact factor: 11.556

Review 6.  Advances in Engineering Cells for Cancer Immunotherapy.

Authors:  Xiao Xu; Teng Li; Shiyang Shen; Jinqiang Wang; Peter Abdou; Zhen Gu; Ran Mo
Journal:  Theranostics       Date:  2019-10-16       Impact factor: 11.556

Review 7.  Targeting Gas6/TAM in cancer cells and tumor microenvironment.

Authors:  Guiling Wu; Zhiqiang Ma; Yicheng Cheng; Wei Hu; Chao Deng; Shuai Jiang; Tian Li; Fulin Chen; Yang Yang
Journal:  Mol Cancer       Date:  2018-01-31       Impact factor: 27.401

8.  Screening for Susceptibility-Related Factors and Biomarkers of Xianling Gubao Capsule-Induced Liver Injury.

Authors:  Chun-Yu Li; Ming Niu; Ya-Lei Liu; Jin-Fa Tang; Wei Chen; Geng Qian; Ming-Yu Zhang; Ya-Fei Shi; Jun-Zhi Lin; Xing-Jie Li; Rui-Sheng Li; Xiao-He Xiao; Guo-Hui Li; Jia-Bo Wang
Journal:  Front Pharmacol       Date:  2020-05-29       Impact factor: 5.810

9.  Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes.

Authors:  Samrat Chakraborty; Zewdu Yilma Dlie; Somdyuti Chakraborty; Somdatta Roy; Biswajit Mukherjee; Shila Elizabeth Besra; Saikat Dewanjee; Alankar Mukherjee; Probir Kumar Ojha; Vinay Kumar; Ramkrishna Sen
Journal:  Mol Ther Nucleic Acids       Date:  2020-02-05       Impact factor: 8.886

Review 10.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.